26.7 C
Delhi
Tuesday, July 15, 2025

Alembic Pharma receives USFDA final approval for Fluorouracil Injection

Date:

Share post:

Donate-GC-Razorpay

Mumbai: Alembic Pharma on Monday said it has received final approval from the US Food & Drug Administration (USFDA) for its Abbreviated New Drug Application (ANDA) Fluorouracil Injection USP, 2.5 g/50 mL (50 mg/mL) Pharmacy Bulk Vial.

The approved ANDA is therapeutically equivalent to the reference listed drug product (RLD), Fluorouracil Injection, 2.5 g/50 mL (50 mg/mL), of Spectrum Pharmaceuticals, Inc. (Spectrum). Fluorouracil Injection is indicated for the treatment of patients with adenocarcinoma of colon and rectum, adenocarcinoma of the breast, gastric adenocarcinoma and pancreatic adenocarcinoma. Refer to our label for full indication.

Fluorouracil Injection USP, 2.5 g/50 mL (50 mg/mL) Vial, has an estimated market size of US$ 5 million for twelve months ending Dec 2022 according to IQVIA.

Related articles

Advocate Neelofar Masood Raises Alarm Over Rising Child Drownings Amid Heatwave, Urges Immediate Government Action

With Jammu and Kashmir grappling with an intense and prolonged heatwave, Senior Jammu & Kashmir National Conference (J&K...

Sabotage From Within: The Next Big Threat to India’s Stability

In the months ahead, the Indian government will not be tested by enemies at the border, but by...

Rouble Nagi-Led Delegation Submits Memorandum to Lieutenant Governor for Empowering Non-Migrant Sikhs

A group of on-ground working youth led by the daughter of Jammu & Kashmir and nationally acclaimed social...

Confidence of New India Will Lead to Viksit Bharat: ‘Viksit Bharat: India @ 2047’ Author Aditya Pittie

Timely and meticulously researched, ‘Viksit Bharat: India @ 2047’, by author and thought leader, Aditya Pittie, provides a...